Cluster analysis of genomic ETV6-RUNX1 (TEL-AML1) fusion sites in childhood acute lymphoblastic leukemia

Leukemia Research

Volumn 33, Issue 8, 2009, Pages 1082-1088

  von Goessel, H ^a   Jacobs, U ^a   Semper, S ^a   Krumbholz, M ^a   Langer, T ^a   Keller, T ^b   Schrauder, A ^c   van der Velden, V H J ^d   van Dongen, J J M ^d   Harbott, J ^e   Panzer Grumayer E R ^f   Schrappe, M ^c   Rascher, W ^a   Metzler, M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b ACOMED Statistik   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

Childhood ALL; Chromosomal translocations; Cluster analysis; ETV6 RUNX1; Genomic fusion sites; TEL AML1

Indexed keywords

TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA RECOMBINATION; DNA SEQUENCE; GENE CLUSTER; GENE SEQUENCE; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN MOTIF; QUANTITATIVE ANALYSIS;

CHILD; CHILD, PRESCHOOL; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; NEOPLASM, RESIDUAL; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; TUMOR MARKERS, BIOLOGICAL;

EID: 67349202133     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.11.001     Document Type: Article

References (43)

1. Borkhardt A., Cazzaniga G., Viehmann S., Valsecchi M.G., Ludwig W.D., Burci L., et al. Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials. Associazione Italiana Ematologia Oncologia Pediatrica and the Berlin-Frankfurt-Munster Study Group. Blood 90 (1997) 571-577
2. Greaves M.F., and Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer 3 (2003) 639-649
3. Zelent A., Greaves M., and Enver T. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia. Oncogene 23 (2004) 4275-4283
4. Wiemels J.L., Cazzaniga G., Daniotti M., Eden O.B., Addison G.M., Masera G., et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet 354 (1999) 1499-1503
5. Ford A.M., Bennett C.A., Price C.M., Bruin M.C., Van Wering E.R., and Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukaemia. Proc Natl Acad Sci USA 95 (1998) 4584-4588
6. Wiemels J.L., Ford A.M., Van Wering E.R., Postma A., and Greaves M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood 94 (1999) 1057-1062
7. Maia A.T., Ford A.M., Jalali G.R., Harrison C.J., Taylor G.M., Eden O.B., et al. Molecular tracking of leukemogenesis in a triplet pregnancy. Blood 98 (2001) 478-482
8. Maia A.T., Koechling J., Corbett R., Metzler M., Wiemels J.L., and Greaves M. Protracted postnatal natural histories in childhood leukemia. Genes Chromosomes Cancer 39 (2004) 335-340
9. Hong D., Gupta R., Ancliff P., Atzberger A., Brown J., Soneji S., et al. Initiating and cancer-propagating cells in TEL-AML1-associated childhood leukemia. Science 319 (2008) 336-339
10. Mori H., Colman S.M., Xiao Z., Ford A.M., Healy L.E., Donaldson C., et al. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc Natl Acad Sci USA 99 (2002) 8242-8247
11. Stanulla M., Wang J., Chervinsky D.S., Thandla S., and Aplan P.D. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol Cell Biol 17 (1997) 4070-4079
12. Aplan P.D., Chervinsky D.S., Stanulla M., and Burhans W.C. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 87 (1996) 2649-2658
13. Lovett B.D., Lo Nigro L., Rappaport E.F., Blair I.A., Osheroff N., Zheng N., et al. Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation. Proc Natl Acad Sci USA 98 (2001) 9802-9807
14. Wiemels J.L., Leonard B.C., Wang Y., Segal M.R., Hunger S.P., Smith M.T., et al. Site-specific translocation and evidence of postnatal origin of the t(1;19) E2A-PBX1 fusion in childhood acute lymphoblastic leukaemia. Proc Natl Acad Sci USA 99 (2002) 15101-15106
15. van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukaemia. Leukemia 13 (1999) 1901-1928
16. Konrad M., Metzler M., Panzer S., Ostreicher I., Peham M., Repp R., et al. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone. Blood 101 (2003) 3635-3640
17. Metzler M., Mann G., Monschein U., Lodzinski M., Gall C., Flohr T., et al. Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene. Haematologica 91 (2006) 683-686
18. Romana S., Poirel H., Della Valle V., Mauchauffe M., Busson-Le Coniat M., Berger R., et al. Molecular analysis of chromosomal breakpoints in three examples of chromosomal translocation involving the TEL gene. Leukemia 13 (1999) 1754-1759
19. Thandla S.P., Ploski J.E., Raza-Egilmez S.Z., Chhalliyil P.P., Block A.W., de Jong P.J., et al. ETV6-AML1 translocation breakpoints cluster near a purine/pyrimidine repeat region in the ETV6 gene. Blood 93 (1999) 293-299
20. Wiemels J.L., and Greaves M. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia. Cancer Res 59 (1999) 4075-4082
21. Wiemels J.L., Alexander F.E., Cazzaniga G., Biondi A., Mayer S.P., and Greaves M. Microclustering of TEL-AML1 translocation breakpoints in childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer 29 (2000) 219-228
22. Andersen M.T., Nordentoft I., Hjalgrim L.L., Christiansen C.L., Jakobsen V.D., Hjalgrim H., et al. Characterization of t(12;21) breakpoint junctions in acute lymphoblastic leukemia. Leukemia 15 (2001) 858-859
23. McHale C.M., Wiemels J.L., Zhang L., Ma X., Buffler P.A., Guo W., et al. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California. Genes Chromosomes Cancer 37 (2003) 36-43
24. Abeysinghe S.S., Chuzhanova N., Krawczak M., Ball E.V., and Cooper D.N. Translocation and gross deletion breakpoints in human inherited disease and cancer I: nucleotide composition and recombination-associated motifs. Hum Mutat 22 (2003) 229-244
25. Segal M.R., and Wiemels J.L. Clustering of translocation breakpoints. J Am Stat Assoc 97 (2002) 66-76
26. Kulldorff M, Information Management Services, Inc. SaTScanTM v7.0: software for the spatial and space-time scan statistics. http://www.satscan.org/; 2006.
27. Sheather S.J., and Jones M.C. A reliable data-based bandwidth selection method for kernel density estimation. J R Stat Soc Ser B 53 (1991) 683-690
28. Wiemels J.L., Xiao Z., Buffler P.A., Maia A.T., Ma X., Dicks B.M., et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood 99 (2002) 3801-3805
29. Kolomietz E., Meyn M.S., Pandita A., and Squire J.A. The role of Alu repeat clusters as mediators of recurrent chromosomal aberrations in tumors. Genes Chromosomes Cancer 35 (2002) 97-112
30. Jeffs A.R., Benjes S.M., Smith T.L., Sowerby S.J., and Morris C.M. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia. Hum Mol Genet 7 (1998) 767-776
31. Strout M.P., Marcucci G., Bloomfield C.D., and Caligiuri M.A. The partial tandem duplication of ALL1 (MLL) is consistently generated by Alu-mediated homologous recombination in acute myeloid leukaemia. Proc Natl Acad Sci USA 95 (1998) 2390-2395
32. Kurahashi H., Inagaki H., Hosoba E., Kato T., Ohye T., Kogo H., et al. Molecular cloning of a translocation breakpoint hotspot in 22q11. Genome Res 17 (2007) 461-469
33. Flohr T., Schrauder A., Cazzaniga G., Panzer-Grumayer R., van der Velden V., Fischer S., et al. Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia. Leukemia 22 (2008) 771-782
34. van Dongen J.J., Seriu T., Panzer-Grumayer E.R., Biondi A., Pongers-Willemse M.J., Corral L., et al. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood. Lancet 352 (1998) 1731-1738
35. Panzer-Grumayer E.R., Cazzaniga G., van der Velden V.H., del Giudice L., Peham M., Mann G., et al. Immunogenotype changes prevail in relapses of young children with TEL-AML1-positive acute lymphoblastic leukemia and derive mainly from clonal selection. Clin Cancer Res 11 (2005) 7720-7727
36. Burmeister T., Marschalek R., Schneider B., Meyer C., Gokbuget N., Schwartz S., et al. Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations. Leukemia 20 (2006) 451-457
37. Busch K., Borkhardt A., Wossmann W., Reiter A., and Harbott J. Combined polymerase chain reaction methods to detect c-myc/IgH rearrangement in childhood Burkitt's lymphoma for minimal residual disease analysis. Haematologica 89 (2004) 818-825
38. Morrow M., Samanta A., Kioussis D., Brady H.J., and Williams O. TEL-AML1 preleukemic activity requires the DNA binding domain of AML1 and the dimerization and corepressor binding domains of TEL. Oncogene 26 (2007) 4404-4414
39. Kobayashi H., Satake N., Maseki N., Sakashita A., and Kaneko Y. The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia. Br J Haematol 94 (1996) 105-111
40. Reichel M., Gillert E., Angermuller S., Hensel J.P., Heidel F., Lode M., et al. Biased distribution of chromosomal breakpoints involving the MLL gene in infants versus children and adults with t(4;11) ALL. Oncogene 20 (2001) 2900-2907
41. Reiter A., Saussele S., Grimwade D., Wiemels J.L., Segal M.R., Lafage-Pochitaloff M., et al. Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia. Genes Chromosomes Cancer 36 (2003) 175-188
42. Xiao Z., Greaves M.F., Buffler P., Smith M.T., Segal M.R., Dicks B.M., et al. Molecular characterization of genomic AML1-ETO fusions in childhood leukemia. Leukemia 15 (2001) 1906-1913
43. Eguchi-Ishimae M., Eguchi M., Ishii E., Miyazaki S., Ueda K., Kamada N., et al. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 97 (2001) 737-743